BRCAT | BRCA1/2 Mutation Analysis, Next-Generation Sequencing, Tumor

This test is intended for identifying specific mutations within the BRCA1 and BRCA2 genes known to be associated with response to PARP inhibitors and sensitivity to platinum-based therapy.

BRFKT | BRAF/KIT Mutation Analysis, Next-Generation Sequencing, Tumor

This test is intended for identifying specific mutations within the BRAF and KIT genes that predict response to therapy.

CMITO | Combined Mitochondrial Full Genome and Nuclear Gene Panel, Varies

This test is intended for diagnosing mitochondrial disease that results from variants in either nuclear-encoded genes or the mitochondrial genome.

CTNBT | B-Catenin Mutations Analysis, Next-Generation Sequencing, Tumor

This test is intended for distinguishing desmoid-type fibromatosis from other soft tissue tumors by assessing gene targets within the beta-catenin (CTNNB1) gene.

ESR1T | ESR1 Mutations Analysis, Next-Generation Sequencing, Tumor

This test is intended for assisting in the clinical management of patients with metastatic breast cancer by identifying tumors with evolving resistance to endocrine therapy.

IDHT | IDH1/IDH2 Mutations Analysis, Next-Generation Sequencing, Tumor

This test is intended for identifying specific mutations within the IDH1 and IDH2genes that assist in tumor diagnosis/classification and predict response to targeted therapy.

IDHQ | IDH1 (R132) and IDH2 (R140 and R172) Quantitative Detection, Droplet Digital PCR, Varies

This test is intended for detecting IDH1 R132 and IDH2 R140 and R172 mutations in acute myeloid leukemia patients at the time of diagnosis to guide targeted therapy.

K11CC | Kelch-Like Protein 11 Antibody, Cell Binding Assay, Spinal Fluid

This test is intended for evaluating patients with paraneoplastic or autoimmune encephalitis (brainstem encephalitis or limbic encephalitis or cerebellar ataxia) using spinal fluid specimens.

K11CS | Kelch-Like Protein 11 Antibody, Cell Binding Assay, Serum

This test is intended for evaluating patients with paraneoplastic or autoimmune encephalitis (brainstem encephalitis or limbic encephalitis or cerebellar ataxia) using serum specimens.

MCCRC | MayoComplete Colorectal Cancer Panel, Next-Generation Sequencing, Tumor

This test is intended for predicting prognosis from microsatellite instability status.

MCGST | MayoComplete Gastrointestinal Stromal Tumor (GIST) Panel, Next-Generation Sequencing, Tumor

This test is intended for establishing diagnosis and identifying targeted therapies for patients with gastrointestinal stromal tumors).

MCLNG | MayoComplete Lung Cancer-Targeted Gene Panel with Rearrangement, Tumor

This test is intended for the diagnosis and management of patients with lung cancer, and for assessment of microsatellite instability.

MCLNM | MayoComplete Lung Cancer Mutations, Next-Generation Sequencing, Tumor

This test is intended for the diagnosis and management of patients with lung cancer.

MCLNR | MayoComplete Lung Rearrangements, Rapid, Tumor

This test is intended for identifying lung tumors that may respond to targeted therapies by simultaneously assessing multiple genes involved in rearrangements resulting in fusion transcripts.

MCMLN | MayoComplete Melanoma Panel, Next-Generation Sequencing, Tumor

This test is intended primarily for determining if patients will respond to targeted therapy.

MCSMP | MayoComplete Sarcoma Mutation Panel, Next-Generation Sequencing, Tumor

This test is intended primarily for identifying mutations that help in the diagnosis of specific soft tissue and bone tumors (sarcoma).

MCSRC | MayoComplete Comprehensive Sarcoma Panel, Next-Generation Sequencing, Tumor

This test is intended primarily for identifying mutations that help in the diagnosis of specific soft tissue and bone tumors (sarcoma). Secondarily for identifying mutations that have therapeutic or prognostic significance.

MPEP | Monoclonal Protein Study, Expanded Panel, Serum

This test is intended for assessing risk of progression from monoclonal gammopathy of undetermined significance to multiple myeloma.

NMITO | Nuclear Mitochondrial Gene Panel, Next-Generation Sequencing, Varies

This test is intended for diagnosing the subset of mitochondrial disease that results from variants in the nuclear-encoded genes.

TP53 | TP53 Mutation Analysis, Next-Generation Sequencing, Tumor

This test is intended for assisting in the clinical management of patients with cancer.

WNCSF | West Nile Virus, RNA, PCR, Molecular Detection, Spinal Fluid

This test is intended for rapid testing of West Nile virus (WNV) RNA (lineage 1 and lineage 2) using cerebrospinal fluid specimens.

WNVBL | West Nile Virus, RNA, PCR, Molecular Detection, Blood

This test is intended for the rapid testing of West Nile virus (WNV) RNA (lineage 1 and lineage 2)

WNVS| West Nile Virus, RNA, PCR, Molecular Detection, Serum

This test is intended for the rapid testing of West Nile virus (WNV) RNA (lineage 1 and lineage 2) using serum specimens.

WNVUR | West Nile Virus, RNA, PCR, Molecular Detection, Random, Urine

This test is intended for the rapid testing of West Nile virus (WNV) RNA (lineage 1 and lineage 2)

XL2T | FOXL2 Mutations Analysis, Next-Generation Sequencing, Tumor

This test is intended for assisting in the clinical diagnosis of adult granulosa cell tumor by assessing gene targets with in the FOXL2 gene.